Benefit of nephrectomy for treating metastatic renal cell carcinoma
Conclusions Patients treated with NEP associated to systemic treatment and with an intermediate/low risk in the Motzer classification had a better PFS and OS. The OS also improves in patients treated with mTOR in second line, and Karnofsky performance status >80% in the univariate study, but not in the multivariable one.
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
More News: Cancer & Oncology | Carcinoma | Kidney Cancer | Nephrectomy | Palliative | Palliative Care | Renal Cell Carcinoma | Study | Urology & Nephrology